Loading...
Reach Banner
Keywords
Last name
Institution

Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Felix Ratjen and Hartmut Grasemann.

 
Connection Strength
 
 
 
16.361
 
  1. Grasemann H, Klingel M, Avolio J, Prentice C, Gonska T, Tullis E, Ratjen F. Long-term effect of CFTR modulator therapy on airway nitric oxide. Eur Respir J. 2020 01; 55(1).
    View in: PubMed
    Score: 0.952
  2. Ratjen F, Waters V, Klingel M, McDonald N, Dell S, Leahy TR, Yau Y, Grasemann H. Changes in airway inflammation during pulmonary exacerbations in patients with cystic fibrosis and primary ciliary dyskinesia. Eur Respir J. 2016 Mar; 47(3):829-36.
    View in: PubMed
    Score: 0.715
  3. Grasemann H, Gonska T, Avolio J, Klingel M, Tullis E, Ratjen F. Effect of ivacaftor therapy on exhaled nitric oxide in patients with cystic fibrosis. J Cyst Fibros. 2015 Nov; 14(6):727-32.
    View in: PubMed
    Score: 0.697
  4. Grasemann H, Jaecklin T, Mehl A, Huang H, Rafii M, Pencharz P, Ratjen F. Multitracer stable isotope quantification of arginase and nitric oxide synthase activity in a mouse model of pseudomonas lung infection. Mediators Inflamm. 2014; 2014:323526.
    View in: PubMed
    Score: 0.654
  5. Grasemann H, Ratjen F. Early lung disease in cystic fibrosis. Lancet Respir Med. 2013 Apr; 1(2):148-57.
    View in: PubMed
    Score: 0.593
  6. Grasemann H, Tullis E, Ratjen F. A randomized controlled trial of inhaled L-arginine in patients with cystic fibrosis. J Cyst Fibros. 2013 Sep; 12(5):468-74.
    View in: PubMed
    Score: 0.587
  7. Grasemann H, Shehnaz D, Enomoto M, Leadley M, Belik J, Ratjen F. L-ornithine derived polyamines in cystic fibrosis airways. PLoS One. 2012; 7(10):e46618.
    View in: PubMed
    Score: 0.576
  8. Ratjen F, Grasemann H. New therapies in cystic fibrosis. Curr Pharm Des. 2012; 18(5):614-27.
    View in: PubMed
    Score: 0.546
  9. Grasemann H, Ratjen F. Nitric oxide and L-arginine deficiency in cystic fibrosis. Curr Pharm Des. 2012; 18(5):726-36.
    View in: PubMed
    Score: 0.546
  10. Grasemann H, Al-Saleh S, Scott JA, Shehnaz D, Mehl A, Amin R, Rafii M, Pencharz P, Belik J, Ratjen F. Asymmetric dimethylarginine contributes to airway nitric oxide deficiency in patients with cystic fibrosis. Am J Respir Crit Care Med. 2011 May 15; 183(10):1363-8.
    View in: PubMed
    Score: 0.512
  11. Grasemann H, Ratjen F. Emerging therapies for cystic fibrosis lung disease. Expert Opin Emerg Drugs. 2010 Dec; 15(4):653-9.
    View in: PubMed
    Score: 0.498
  12. Grasemann H, Ratjen F. Editorial: leukocyte trafficking and matrix metalloproteinase-8 in obliterative bronchiolitis. J Leukoc Biol. 2010 Jan; 87(1):23-4.
    View in: PubMed
    Score: 0.476
  13. Grasemann H, Tschiedel E, Groch M, Klepper J, Ratjen F. Exhaled nitric oxide in children after accidental exposure to chlorine gas. Inhal Toxicol. 2007 Aug; 19(10):895-8.
    View in: PubMed
    Score: 0.402
  14. Grasemann H, Stehling F, Brunar H, Widmann R, Laliberte TW, Molina L, Döring G, Ratjen F. Inhalation of Moli1901 in patients with cystic fibrosis. Chest. 2007 May; 131(5):1461-6.
    View in: PubMed
    Score: 0.395
  15. Grasemann H, Schwiertz R, Grasemann C, Vester U, Racké K, Ratjen F. Decreased systemic bioavailability of L-arginine in patients with cystic fibrosis. Respir Res. 2006 Jun 09; 7:87.
    View in: PubMed
    Score: 0.371
  16. Grasemann H, Kurtz F, Ratjen F. Inhaled L-arginine improves exhaled nitric oxide and pulmonary function in patients with cystic fibrosis. Am J Respir Crit Care Med. 2006 Jul 15; 174(2):208-12.
    View in: PubMed
    Score: 0.368
  17. Ratjen F, Rietschel E, Kasel D, Schwiertz R, Starke K, Beier H, van Koningsbruggen S, Grasemann H. Pharmacokinetics of inhaled colistin in patients with cystic fibrosis. J Antimicrob Chemother. 2006 Feb; 57(2):306-11.
    View in: PubMed
    Score: 0.361
  18. Grasemann H, Schwiertz R, Matthiesen S, Racké K, Ratjen F. Increased arginase activity in cystic fibrosis airways. Am J Respir Crit Care Med. 2005 Dec 15; 172(12):1523-8.
    View in: PubMed
    Score: 0.353
  19. Grasemann H, Grasemann C, Kurtz F, Tietze-Schillings G, Vester U, Ratjen F. Oral L-arginine supplementation in cystic fibrosis patients: a placebo-controlled study. Eur Respir J. 2005 Jan; 25(1):62-8.
    View in: PubMed
    Score: 0.336
  20. Grasemann H, Ratjen F. Gender-specific disease modification by NOS3. Br J Haematol. 2004 Jul; 126(1):160; author reply 161.
    View in: PubMed
    Score: 0.325
  21. Grasemann H, Storm van's Gravesande K, Buscher R, Drazen JM, Ratjen F. Effects of sex and of gene variants in constitutive nitric oxide synthases on exhaled nitric oxide. Am J Respir Crit Care Med. 2003 Apr 15; 167(8):1113-6.
    View in: PubMed
    Score: 0.294
  22. Grasemann H, Storm van's Gravesande K, Buscher R, Knauer N, Silverman ES, Palmer LJ, Drazen JM, Ratjen F. Endothelial nitric oxide synthase variants in cystic fibrosis lung disease. Am J Respir Crit Care Med. 2003 Feb 01; 167(3):390-4.
    View in: PubMed
    Score: 0.285
  23. Grasemann H, Ratjen F. [Pulmonary metabolism of nitric oxide (NO) in patients with cystic fibrosis]. Pneumologie. 2002 Jun; 56(6):376-81.
    View in: PubMed
    Score: 0.281
  24. Grasemann H, Storm van's Gravesande K, Gärtig S, Kirsch M, Büscher R, Drazen JM, Ratjen F. Nasal nitric oxide levels in cystic fibrosis patients are associated with a neuronal NO synthase (NOS1) gene polymorphism. Nitric Oxide. 2002 Mar; 6(2):236-41.
    View in: PubMed
    Score: 0.276
  25. Grasemann H, Ratjen F. Different subgroups of difficult asthma in children. Thorax. 2001 Nov; 56(11):895.
    View in: PubMed
    Score: 0.270
  26. Grasemann H, Knauer N, Büscher R, Hübner K, Drazen JM, Ratjen F. Airway nitric oxide levels in cystic fibrosis patients are related to a polymorphism in the neuronal nitric oxide synthase gene. Am J Respir Crit Care Med. 2000 Dec; 162(6):2172-6.
    View in: PubMed
    Score: 0.253
  27. Ratjen F, Kavuk I, Gärtig S, Wiesemann HG, Grasemann H. Airway nitric oxide in infants with acute wheezy bronchitis. Pediatr Allergy Immunol. 2000 Nov; 11(4):230-5.
    View in: PubMed
    Score: 0.252
  28. Pollak M, Shaw M, Wilson D, Grasemann H, Ratjen F. Bronchodilator responsiveness in children with cystic fibrosis and allergic bronchopulmonary aspergillosis. Eur Respir J. 2020 Aug; 56(2).
    View in: PubMed
    Score: 0.249
  29. Grasemann H, Gaston B, Fang K, Paul K, Ratjen F. Decreased levels of nitrosothiols in the lower airways of patients with cystic fibrosis and normal pulmonary function. J Pediatr. 1999 Dec; 135(6):770-2.
    View in: PubMed
    Score: 0.236
  30. Grasemann H, Ratjen F. Cystic fibrosis lung disease: the role of nitric oxide. Pediatr Pulmonol. 1999 Dec; 28(6):442-8.
    View in: PubMed
    Score: 0.236
  31. Ratjen F, Gärtig S, Wiesemann HG, Grasemann H. Effect of inhaled nitric oxide on pulmonary function in cystic fibrosis. Respir Med. 1999 Aug; 93(8):579-83.
    View in: PubMed
    Score: 0.231
  32. Grasemann H, Gärtig SS, Wiesemann HG, Teschler H, Konietzko N, Ratjen F. Effect of L-arginine infusion on airway NO in cystic fibrosis and primary ciliary dyskinesia syndrome. Eur Respir J. 1999 Jan; 13(1):114-8.
    View in: PubMed
    Score: 0.222
  33. Ratjen F, Klingel M, Black P, Powers MR, Grasemann H, Solomon M, Sagel SD, Donaldson SH, Rowe SM, Rosenfeld M. Changes in Lung Clearance Index in Preschool-aged Patients with Cystic Fibrosis Treated with Ivacaftor (GOAL): A Clinical Trial. Am J Respir Crit Care Med. 2018 08 15; 198(4):526-528.
    View in: PubMed
    Score: 0.216
  34. Grasemann H, Ioannidis I, Tomkiewicz RP, de Groot H, Rubin BK, Ratjen F. Nitric oxide metabolites in cystic fibrosis lung disease. Arch Dis Child. 1998 Jan; 78(1):49-53.
    View in: PubMed
    Score: 0.207
  35. Grasemann H, Michler E, Wallot M, Ratjen F. Decreased concentration of exhaled nitric oxide (NO) in patients with cystic fibrosis. Pediatr Pulmonol. 1997 Sep; 24(3):173-7.
    View in: PubMed
    Score: 0.202
  36. Grasemann H, Ciet P, Amin R, McDonald N, Klingel M, Tiddens HAWM, Ratjen F, Grosse-Wortmann L. Changes in magnetic resonance imaging scores and ventilation inhomogeneity in children with cystic fibrosis pulmonary exacerbations. Eur Respir J. 2017 08; 50(2).
    View in: PubMed
    Score: 0.202
  37. Grasemann H, Ioannidis I, de Groot H, Ratjen F. Metabolites of nitric oxide in the lower respiratory tract of children. Eur J Pediatr. 1997 Jul; 156(7):575-8.
    View in: PubMed
    Score: 0.200
  38. Grasemann H, Wiesemann HG, Ratjen F. [The importance of lung function as a predictor of 2-year mortality in mucoviscidosis]. Pneumologie. 1995 Aug; 49(8):466-9.
    View in: PubMed
    Score: 0.175
  39. Waters VJ, Stanojevic S, Sonneveld N, Klingel M, Grasemann H, Yau YC, Tullis E, Wilcox P, Freitag A, Chilvers M, Ratjen FA. Factors associated with response to treatment of pulmonary exacerbations in cystic fibrosis patients. J Cyst Fibros. 2015 Nov; 14(6):755-62.
    View in: PubMed
    Score: 0.170
  40. Jaecklin T, Duerr J, Huang H, Rafii M, Bear CE, Ratjen F, Pencharz P, Kavanagh BP, Mall MA, Grasemann H. Lung arginase expression and activity is increased in cystic fibrosis mouse models. J Appl Physiol (1985). 2014 Aug 01; 117(3):284-8.
    View in: PubMed
    Score: 0.162
  41. Mehl A, Ghorbani P, Douda D, Huang H, Palaniyar N, Ratjen F, Grasemann H. Effect of arginase inhibition on pulmonary L-arginine metabolism in murine Pseudomonas pneumonia. PLoS One. 2014; 9(3):e90232.
    View in: PubMed
    Score: 0.159
  42. Grasemann H, Ratjen F, Solomon M. Aquagenic wrinkling of the palms in a patient with cystic fibrosis. N Engl J Med. 2013 Dec 12; 369(24):2362-3.
    View in: PubMed
    Score: 0.156
  43. Amin R, Charron M, Grinblat L, Shammas A, Grasemann H, Graniel K, Ciet P, Tiddens H, Ratjen F. Cystic fibrosis: detecting changes in airway inflammation with FDG PET/CT. Radiology. 2012 Sep; 264(3):868-75.
    View in: PubMed
    Score: 0.142
  44. Al-Saleh S, Dell SD, Grasemann H, Yau YC, Waters V, Martin S, Ratjen F. Sputum induction in routine clinical care of children with cystic fibrosis. J Pediatr. 2010 Dec; 157(6):1006-1011.e1.
    View in: PubMed
    Score: 0.123
  45. Grasemann C, Ratjen F, Schnabel D, Reutershahn E, Vester U, Grasemann H. Effect of growth hormone therapy on nitric oxide formation in cystic fibrosis patients. Eur Respir J. 2008 Apr; 31(4):815-21.
    View in: PubMed
    Score: 0.103
  46. Ratjen F, Walter H, Haug M, Meisner C, Grasemann H, Döring G. Diagnostic value of serum antibodies in early Pseudomonas aeruginosa infection in cystic fibrosis patients. Pediatr Pulmonol. 2007 Mar; 42(3):249-55.
    View in: PubMed
    Score: 0.098
  47. Stehling F, Roll C, Ratjen F, Grasemann H. Nasal nitric oxide to diagnose primary ciliary dyskinesia in newborns. Arch Dis Child Fetal Neonatal Ed. 2006 May; 91(3):F233.
    View in: PubMed
    Score: 0.092
  48. Tschiedel E, Grasemann H, Ratjen F. Mycobacterium chelonae in a CF patient with anaplastic large cell lymphoma. J Cyst Fibros. 2006 May; 5(2):133-6.
    View in: PubMed
    Score: 0.090
  49. Knauer N, Ratjen F, Grasemann H. [Cystic fibrosis modifying genes]. Pneumologie. 2005 Jun; 59(6):395-404.
    View in: PubMed
    Score: 0.087
  50. Straub V, Ratjen F, Amthor H, Voit T, Grasemann H. Airway nitric oxide in Duchenne muscular dystrophy. J Pediatr. 2002 Jul; 141(1):132-4.
    View in: PubMed
    Score: 0.071
  51. Büscher R, Eilmes KJ, Grasemann H, Torres B, Knauer N, Sroka K, Insel PA, Ratjen F. beta2 adrenoceptor gene polymorphisms in cystic fibrosis lung disease. Pharmacogenetics. 2002 Jul; 12(5):347-53.
    View in: PubMed
    Score: 0.071
  52. Ratjen F, Grasemann H, Wolstein R, Wiesemann HG. Isovolume pressure/flow curves of rapid thoracoabdominal compressions in infants without respiratory disease. Pediatr Pulmonol. 1998 Sep; 26(3):197-203.
    View in: PubMed
    Score: 0.054
  53. Yau YC, Ratjen F, Tullis E, Wilcox P, Freitag A, Chilvers M, Grasemann H, Zlosnik J, Speert D, Corey M, Stanojevic S, Matukas L, Leahy TR, Shih S, Waters V. Randomized controlled trial of biofilm antimicrobial susceptibility testing in cystic fibrosis patients. J Cyst Fibros. 2015 Mar; 14(2):262-6.
    View in: PubMed
    Score: 0.042
  54. Corvol H, Beucher J, Boëlle PY, Busson PF, Muselet-Charlier C, Clement A, Ratjen F, Grasemann H, Laki J, Palmer CN, Elborn JS, Mehta A. Ancestral haplotype 8.1 and lung disease severity in European cystic fibrosis patients. J Cyst Fibros. 2012 Jan; 11(1):63-7.
    View in: PubMed
    Score: 0.034
  55. Mateos-Corral D, Coombs R, Grasemann H, Ratjen F, Dell SD. Diagnostic value of nasal nitric oxide measured with non-velum closure techniques for children with primary ciliary dyskinesia. J Pediatr. 2011 Sep; 159(3):420-4.
    View in: PubMed
    Score: 0.033
  56. Barnes PJ, Dweik RA, Gelb AF, Gibson PG, George SC, Grasemann H, Pavord ID, Ratjen F, Silkoff PE, Taylor DR, Zamel N. Exhaled nitric oxide in pulmonary diseases: a comprehensive review. Chest. 2010 Sep; 138(3):682-92.
    View in: PubMed
    Score: 0.031
  57. Corvol H, Boelle PY, Brouard J, Knauer N, Chadelat K, Henrion-Caude A, Flamant C, Muselet-Charlier C, Boule M, Fauroux B, Vallet C, Feingold J, Ratjen F, Grasemann H, Clement A. Genetic variations in inflammatory mediators influence lung disease progression in cystic fibrosis. Pediatr Pulmonol. 2008 Dec; 43(12):1224-32.
    View in: PubMed
    Score: 0.028
  58. Büscher R, Hoerning A, Patel HH, Zhang S, Arthur DB, Grasemann H, Ratjen F, Insel PA. P2Y2 receptor polymorphisms and haplotypes in cystic fibrosis and their impact on Ca2+ influx. Pharmacogenet Genomics. 2006 Mar; 16(3):199-205.
    View in: PubMed
    Score: 0.023
  59. Tang CM, Hoerning A, Büscher R, O'Connor DT, Ratjen F, Grasemann H, Insel PA. Human adenosine 2B receptor: SNP discovery and evaluation of expression in patients with cystic fibrosis. Pharmacogenet Genomics. 2005 May; 15(5):321-7.
    View in: PubMed
    Score: 0.022
  60. Brouard J, Knauer N, Boelle PY, Corvol H, Henrion-Caude A, Flamant C, Bremont F, Delaisi B, Duhamel JF, Marguet C, Roussey M, Miesch MC, Chadelat K, Boule M, Fauroux B, Ratjen F, Grasemann H, Clement A. Influence of interleukin-10 on Aspergillus fumigatus infection in patients with cystic fibrosis. J Infect Dis. 2005 Jun 01; 191(11):1988-91.
    View in: PubMed
    Score: 0.021
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.